ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc (HEPA)

0,1688
0,0056
(3,43%)
Geschlossen 09 Februar 10:00PM
0,1678
-0,001
(-0,59%)
Nach Börsenschluss: 1:59AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,1678
Gebot
0,1678
Fragen
1,00
Volumen
6.477.634
0,1645 Tagesbereich 0,176
0,121 52-Wochen-Bereich 3,4899
Marktkapitalisierung
Handelsende
0,1632
Handelsbeginn
0,17
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.100.070
VWAP
0,169826
Durchschnittliches Volumen (3 Mio.)
9.098.714
Ausgegebene Aktien
6.958.371
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,02
Gewinn pro Aktie (EPS)
-7,03
Erlöse
-
Nettogewinn
-48,93M

Über Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0,16. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0,121 to US$ 3,4899.

Hepion Pharmaceuticals currently has 6.958.371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$1,14 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.02.

HEPA Neueste Nachrichten

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0162-8.804347826090.1840.18580.14970508680.16842156CS
4-0.3822-69.49090909090.550.550.121271970400.20404832CS
12-0.4684-73.62464633760.63620.740.12190987140.20545758CS
26-0.4822-74.18461538460.650.890.12139536850.20839104CS
52-1.4222-89.44654088051.593.48990.12120340210.23846191CS
156-19.4322-99.14387755119.626.60.1218506793.17528303CS
260-101.8322-99.8354901961102123.60.121126352127.43338029CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?
The current share price of Hepion Pharmaceuticals is US$ 0,1678
How many Hepion Pharmaceuticals shares are in issue?
Hepion Pharmaceuticals has 6.958.371 shares in issue
What is the market cap of Hepion Pharmaceuticals?
The market capitalisation of Hepion Pharmaceuticals is USD 1,14M
What is the 1 year trading range for Hepion Pharmaceuticals share price?
Hepion Pharmaceuticals has traded in the range of US$ 0,121 to US$ 3,4899 during the past year
What is the PE ratio of Hepion Pharmaceuticals?
The price to earnings ratio of Hepion Pharmaceuticals is -0,02
What is the reporting currency for Hepion Pharmaceuticals?
Hepion Pharmaceuticals reports financial results in USD
What is the latest annual profit for Hepion Pharmaceuticals?
The latest annual profit of Hepion Pharmaceuticals is USD -48,93M
What is the registered address of Hepion Pharmaceuticals?
The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Hepion Pharmaceuticals website address?
The website address for Hepion Pharmaceuticals is www.hepion.com
Which industry sector does Hepion Pharmaceuticals operate in?
Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,28M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,15M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
47,43M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,4M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,08M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock